Diagnostics firm QuidelOrtho Corp is looking to sell its point-of-care testing unit at a valuation of $1.5 billion, the Financial Times reported.
Private equity firms ranging from Advent International to SK Capital Partners and Archimed have expressed interest in the asset, according to the FT report, which cited people familiar with the matter.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.